The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Rising incidence of adenocarcinoma of the esophagus and gastric cardia
Blot, W. J. (1991) · JAMA · doi:10.1001/jama.265.10.1287 · Cited by 2,354
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., & Isakson, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12013 · Cited by 1,551
Is there publication bias in the reporting of cancer risk in Barrett's esophagus?
Shaheen, N. J., Crosby, M. A., Bozymski, E. M., & Sandler, R. S. (2000) · Gastroenterology · doi:10.1053/gast.2000.9302 · Cited by 758
The Incidence of Adenocarcinoma in Columnar-Lined (Barrett's) Esophagus
Cameron, A. J., Ott, B. J., & Payne, W. S. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131404 · Cited by 715
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119400 · Cited by 712
Winters, C., Spurling, T. J., Chobanian, S. J., Curtis, D. J., Esposito, R. L., Hacker, J. F., Johnson, D. A., Cruess, D. F., Cotelingam, J. D., Gurney, M. S., et al. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90847-x · Cited by 689
Spechler, S. J., & Goyal, R. K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608073150605 · Cited by 660
Cited by
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,014
Self-citationAmerican Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M., & Shaheen, N. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.031 · Cited by 1,060
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
Subbaramaiah, K., & Dannenberg, A. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00043-3 · Cited by 649
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
Warner, T. D., & Mitchell, J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0645rev · Cited by 614
Souza, R. F., Huo, X., Mittal, V., Schuler, C. M., Carmack, S. W., Zhang, H. Y., Zhang, X., Yu, C., Hormi–Carver, K., Genta, R. M., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.055 · Cited by 406
Cyclooxygenase-2 and Epidermal Growth Factor Receptor: Pharmacologic Targets for Chemoprevention
Dannenberg, A. J., Lippman, S. M., Mann, J. R., Subbaramaiah, K., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.112 · Cited by 404
Chun, K.-S., & Surh, Y.-J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.031 · Cited by 402
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
Reid, B. J., Li, X., Galipeau, P. C., & Vaughan, T. L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2773 · Cited by 378
Epidemiology of upper gastrointestinal malignancies
CREW, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.04.021 · Cited by 323
The tumor microenvironment in esophageal cancer
Lin, E. W., Karakasheva, T. A., Hicks, P. D., Bass, A. J., & Rustgi, A. K. (2016) · Oncogene · doi:10.1038/onc.2016.34 · Cited by 303
Shaheen, N. J., & Richter, J. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60487-6 · Cited by 287
Barrett Esophagus and Risk of Esophageal Cancer: A Clinical Review
Spechler, S. J. (2013) · JAMA · doi:10.1001/jama.2013.226450 · Cited by 284
Wang, J.-H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i11.1647 · Cited by 188
Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus
Nguyen, D. M., El-Serag, H. B., Henderson, L., Stein, D., Bhattacharyya, A., & Sampliner, R. E. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.06.001 · Cited by 159
Kelly, R. J., Ansari, A. M., Miyashita, T., Zahurak, M., Lay, F., Ahmed, A. K., Born, L. J., Pezhouh, M. K., Salimian, K. J., Ng, C., et al. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000003455 · Cited by 22
Metadata
- Authors
- Buttar, N. S., Wang, K. K., Leontovich, O., Westcott, J. Y., Pacifico, R. J., Anderson, M. A., Krishnadath, K. K., Lutzke, L. S., & Burgart, L. J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 122
- Issue
- 4
- Pages
- 1101-1112
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1997850959
- Cited by
- 348
- References
- 33
- FWCI
- 29.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.